Advancing Ocular Gene Therapy Delivery: Suprachoroidal Innovations
Time: 9:00 am
day: Pre-Conference Workshop Day Preclinical track AM
Details:
Optimizing ocular gene therapy delivery methods is crucial for enhancing treatment efficacy and minimizing invasiveness. This workshop focuses on the emerging technique of suprachoroidal delivery, offering insights into its benefits, challenges, and potential to revolutionize ocular gene therapy.
Key Discussion Points:
- Overview of Suprachoroidal Delivery: Exploring the concept and potential benefits of suprachoroidal delivery in ocular gene therapy. Understanding the challenges and limitations, including precision targeting within the small space of the eye.
- Advancements in Ocular Delivery Technologies: Investigating emerging approaches like RNA editing and splicing for enhancing therapeutic agent delivery to the retina. Exploring lipid nanoparticle-based delivery systems and their applications in ocular gene therapy.
- Suprachoroidal Delivery and Bioavailability: Assessing the role of suprachoroidal delivery in enhancing bioavailability of therapeutic agents in ocular gene therapy. Overview of Clearside Biomedical’s expertise and experience in developing suprachoroidal delivery technologies.
- Financial Investment and Regulatory Pathways: Discussing the financial investment required for developing suprachoroidal delivery devices. Exploring regulatory pathways and considerations for the approval of suprachoroidal delivery systems in ocular gene therapy.
By the end of this workshop, participants will gain a comprehensive understanding of suprachoroidal delivery and acquire insights into its potential to enhance bioavailability, challenges
